Benitec Biopharma (BNTC) Operating Margin (2019 - 2023)
Benitec Biopharma (BNTC) posted Operating Margin of 65000.0% for Q2 2023, down 708.57% sequentially from 8038.89% in Q1 2023.
Benitec Biopharma (BNTC) Operating Margin (2019 - 2023) Analysis & Trends
Benitec Biopharma has reported Operating Margin for 5 years, with the latest figure at 65000.0% in Q2 2023.
- Quarterly Operating Margin changed N/A year-over-year to 65000.0% in Q2 2023, while the trailing twelve-month figure through Mar 2024 was 307028.57% (down 27869181.0% YoY) and the FY2023 annual result came in at 25441.33%, down 98380.0% from the prior year.
- Operating Margin fell to 65000.0% in Q2 2023 per BNTC's latest filing, from 8038.89% in the prior quarter.
- Over five years, Operating Margin peaked at 8248.57% in Q2 2020 and troughed at 379300.0% in Q1 2021.
- A 5-year average of 80620.4% and a median of 8038.89% in 2023 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2021 and 2022: Operating Margin slumped 37176071 bps in 2021, then soared 37209167 bps in 2022.
- Over 5 years, Operating Margin stood at 2741.56% in 2019, then sank by 11787 bps to 325900.0% in 2020, then surged by 94 bps to 19340.0% in 2021, then sank by 107 bps to 40071.43% in 2022, then tumbled by 62 bps to 65000.0% in 2023.
- According to Business Quant data, Operating Margin over the past three periods registered 65000.0%, 8038.89%, and 40071.43% for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -65,000.00% |
| Mar 31, 2023 | -8,038.89% |
| Dec 31, 2022 | -40,071.43% |
| Mar 31, 2022 | -7,208.33% |
| Dec 31, 2021 | -19,340.00% |
| Jun 30, 2021 | -192,750.00% |
| Mar 31, 2021 | -379,300.00% |
| Dec 31, 2020 | -325,900.00% |
| Sep 30, 2020 | -4,890.91% |
| Jun 30, 2020 | 8,248.57% |
| Mar 31, 2020 | -7,539.29% |
| Dec 31, 2019 | -2,741.56% |
| Sep 30, 2019 | -3,533.33% |